How would you manage a patient with high risk prostate cancer with rising PSA after RP who has oligometastatic bone disease in the pelvis?

Would you recommend radiation to the prostatic fossa and/or the oligometastatic site? How would you dose these areas? Would you recommend ADT?

Answer from: Radiation Oncologist at Community Practice

For now, the standard of care is systemic treatment of which the type is sometimes driven by extent of bony disease.

Comments

Radiation Oncologist at Compass Oncology
Thanks for the response. Question becomes: was the...